Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Weiner

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Molecular Pharmaceutics|November 4, 2014
A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola InfectionJin Huk Choi, Kristina Jonsson-Schmunk, Xiangguo Qiu, et al.
Neurotrauma Reports|May 1, 2025
Lessons Learned and Recommendations from a SCOPE Spinal Cord Injury Neurorestorative Clinical Trials UpdateBethany R Kondiles, Sabhya Rana, David Weiner, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
PD-1 blockade drug holiday improves exhausted progenitor CD8 T cell (Tpex) reinvigoration by avoiding Tpex adaptive resistanceShin Foong Ngiow, Ryan P O'Connell, Sasikanth Manne, et al.
Nature Communications|August 23, 2019
Repeated semen exposure decreases cervicovaginal SIVmac251 infection in rhesus macaquesShaheed A Abdulhaqq, Melween Martinez, Guobin Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2024
Ammonia transporter RhBG initiates downstream signaling and functional responses by activating NFκBSaurabh Mishra, Nicole Welch, Shashi Shekhar Singh, et al.
Plos One|January 13, 2012
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV controlBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2018
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck CancerCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Targeting LxCxE cleft pocket of retinoblastoma protein in M2 macrophages inhibits ovarian cancer progressionEvgenii N Tcyganov, Taekyoung Kwak, Xue Yang, et al.
The Journal of Infectious Diseases|October 3, 2017
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR BoostJulie A Ake, Alexandra Schuetz, Poonam Pegu, et al.
Vaccine|March 22, 2026
DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant proteinStephen C De Rosa, Ronnie M Gravett, William O Hahn, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Molecular Pharmaceutics|November 4, 2014
A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola InfectionJin Huk Choi, Kristina Jonsson-Schmunk, Xiangguo Qiu, et al.
Neurotrauma Reports|May 1, 2025
Lessons Learned and Recommendations from a SCOPE Spinal Cord Injury Neurorestorative Clinical Trials UpdateBethany R Kondiles, Sabhya Rana, David Weiner, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
PD-1 blockade drug holiday improves exhausted progenitor CD8 T cell (Tpex) reinvigoration by avoiding Tpex adaptive resistanceShin Foong Ngiow, Ryan P O'Connell, Sasikanth Manne, et al.
Nature Communications|August 23, 2019
Repeated semen exposure decreases cervicovaginal SIVmac251 infection in rhesus macaquesShaheed A Abdulhaqq, Melween Martinez, Guobin Kang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2024
Ammonia transporter RhBG initiates downstream signaling and functional responses by activating NFκBSaurabh Mishra, Nicole Welch, Shashi Shekhar Singh, et al.
Plos One|January 13, 2012
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV controlBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2018
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck CancerCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Targeting LxCxE cleft pocket of retinoblastoma protein in M2 macrophages inhibits ovarian cancer progressionEvgenii N Tcyganov, Taekyoung Kwak, Xue Yang, et al.
The Journal of Infectious Diseases|October 3, 2017
Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR BoostJulie A Ake, Alexandra Schuetz, Poonam Pegu, et al.
Vaccine|March 22, 2026
DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant proteinStephen C De Rosa, Ronnie M Gravett, William O Hahn, et al.
Pageof 12